Xi Chen, Xi Chen, Mingye Zhao, Mingye Zhao, Lei Tian, & Lei Tian. (2023). Economic evaluation of five first-line PD-(L)1 inhibitors for treating non-squamous non-small cell lung cancer in China: A cost-effectiveness analysis based on network meta-analysis. Frontiers Media S.A..
Chicago Style (17th ed.) CitationXi Chen, Xi Chen, Mingye Zhao, Mingye Zhao, Lei Tian, and Lei Tian. Economic Evaluation of Five First-line PD-(L)1 Inhibitors for Treating Non-squamous Non-small Cell Lung Cancer in China: A Cost-effectiveness Analysis Based on Network Meta-analysis. Frontiers Media S.A., 2023.
MLA (9th ed.) CitationXi Chen, et al. Economic Evaluation of Five First-line PD-(L)1 Inhibitors for Treating Non-squamous Non-small Cell Lung Cancer in China: A Cost-effectiveness Analysis Based on Network Meta-analysis. Frontiers Media S.A., 2023.